Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart

Iacopo Fabiani1, Nicola Riccardo Pugliese1, Salvatore La Carrubba2

  • 1Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Pisa, Italy.

Insights

A new complex remodeling classification (CRC) accurately predicts poor outcomes in asymptomatic patients with arterial hypertension (AH). This advanced assessment tool identifies high-risk individuals, enabling proactive cardiovascular management.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Hypertension Research

Background:

  • Arterial hypertension (AH) poses significant cardiovascular risks.
  • Assessing cardiac remodeling is crucial for prognostication in hypertensive patients.
  • Current classifications may not fully capture prognostic information in asymptomatic individuals.

Purpose of the Study:

  • To evaluate the prognostic impact of a novel complex remodeling classification (CRC) in asymptomatic patients with arterial hypertension (AH).
  • To determine if CRC is an independent predictor of adverse cardiovascular events in this population.

Main Methods:

  • Retrospective analysis of 749 asymptomatic hypertensive patients (Stages A/B heart failure).
  • CRC assessment included indexed left ventricular mass, end-diastolic volume, and relative wall thickness.
  • A composite endpoint (mortality, MI, revascularization, stroke, pulmonary edema) was tracked over 45 months.

Main Results:

  • Kaplan-Meier analysis revealed significantly different survival across CRC-derived classes (P < .001).
  • Cox regression identified CRC as an independent predictor of poor outcome (P = .01) after adjusting for multiple confounders.
  • 73 events (9.7%) were observed during follow-up.

Conclusions:

  • The complex remodeling classification (CRC) is a valuable independent predictor of adverse outcomes in asymptomatic patients with arterial hypertension.
  • CRC offers enhanced prognostic stratification beyond traditional risk factors and classic remodeling assessments.
  • This classification may guide more precise cardiovascular risk management strategies in hypertensive individuals.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
486
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
746
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551